ANTARES PHARMA INC - COM (ATRS)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM
Total 13F shares
82,513,474
Share change
+9,032,826
Total reported value
$339,492,431
Put/Call ratio
163%
Price per share
$4.11
Number of holders
169
Value change
+$37,553,202
Number of buys
74
Number of sells
70

Institutional Holders of ANTARES PHARMA INC - COM (ATRS) as of Q1 2021

As of 31 Mar 2021, ANTARES PHARMA INC - COM (ATRS) was held by 169 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 82,513,474 shares. The largest 10 holders included BlackRock Inc., Rubric Capital Management LP, VANGUARD GROUP INC, STATE STREET CORP, FMR LLC, Sargent Investment Group, LLC, Centric Wealth Management, GEODE CAPITAL MANAGEMENT, LLC, Nuveen Asset Management, LLC, and ORACLE INVESTMENT MANAGEMENT INC. This page lists 169 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.